Trial Information

Summary: Advanced Non-Small Cell Lung Cancer (NSCLC)

A clinical study involving an experimental dual drug approach to treating Advanced Non-Small Cell Lung Cancer (NSCLC) after failure of standard first-line chemotherapy.

Mount Sinai School of Medicine is conducting a clinical study to evaluate the efficacy and safety of a dual drug approach compared to a standard chemotherapy single drug approach in subjects with advanced NSCLC.

You may participate in this study if you:

• Have Advanced Non-Small Cell Lung Cancer
• Have failed standard first-line chemotherapy treatment.

You may not participate in this study if you:

• Have not had prior treatment or had more than one prior chemotherapy treatment as first line treatment for advanced stage disease.
• Have evidence of internal bleeding.
• Have evidence of cancer spreading to the brain.
• Are taking medication to stop blood clots.
• Are on an aspirin or non-steroidal anti inflammatory drug regimen.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 2:29:47 PM